Home
Conditions
Liver Diseases

Clinical trial condition

Liver Diseases

Explore clinical trials studying Liver Diseases. Study availability and eligibility vary by location and protocol.

8,347 public trials 1,303 recruiting studies

Refine in advanced search Browse all conditions

Liver Diseases trial results

Recruiting

Sequential or Up-front Triple Treatment With Durvalumab, Tremelimumab and Bevacizumab for Non-resectable Hepatocellular Carcinoma (HCC) Patients

NCT05844046

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Hospital of the University of Munich Munich, Germany

Klinikum Rechts der Isar of the Technical University Munich Munich, Germany

Würzburg University Hospital Würzburg, Germany

View Trial Details

Recruiting

Effect of 4 Weeks of Oral D. Piger on Safety, Pharmacokinetics and Ethanol Metabolism in Overweight Individuals (2023)

NCT06502834

Conditions: Body Weight, Digestive System Diseases, Fatty Liver, +14 more
Locations: Amsterdam UMC location AMC Amsterdam, Netherlands

View Trial Details

Recruiting

Efficacy of TEAS on Postoperative Pain and Recovery in Patients Undergoing Hepatectomy

NCT06341270

Conditions: Digestive System Diseases, Digestive System Neoplasms, Liver Cancer, +4 more
Locations: West China Hospital Chengdu, Sichuan, China

View Trial Details

Recruiting

Non-invasive Tools for PSVD Diagnosis

NCT06500403

Conditions: Digestive System Diseases, Hypertension, Portal, Idiopathic Noncirrhotic Portal Hypertension, +3 more
Locations: Nanfang hospital, Southern Medical Uiversity Guangzhou, Guangdong, China

View Trial Details

Recruiting

Adjuvant Treatment of Patients With High Risk of Recurrent Hepatocellular Carcinoma With Donafenib in Combination With Envafolimab

NCT06498622

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: No.2 People's Hospital of Fuyang city Fuyang, Anhui, China

Anhui province hospital Hefei, Anhui, China

View Trial Details

Recruiting

Fecal Microbiota Analysis of PNPLA3 Polymorphism in Hispanic Patients With MASLD

NCT06495333

Conditions: Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations: FDI Clinical Research San Juan, Puerto Rico

View Trial Details

Recruiting

Neoadjuvant Intra-tumor Double Immunotherapy for Hepatocellular Carcinoma.

NCT06492408

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations: The Second Affiliated Hospital of Guangzhou Medical University Guanzhou, Guangdong, China

View Trial Details

Recruiting

Vigorous- Versus Moderate-intensity Exercise to Reduce Liver Fat in Adults With Obesity and NAFLD

NCT06124456

Conditions: Behavior, Body Weight, Digestive System Diseases, +12 more
Locations: LKS Faculty of Medicine Hong Kong

View Trial Details

Recruiting

TACE Combined With Immune Checkpoint Inhibitors for Liver Malignant Tumors

NCT06487663

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +13 more
Locations: Tianjin Medical University Cancer Institute and Hospital Tianjin, China

View Trial Details

Recruiting

The National Australian HCV Point-of-Care Testing Program - HCV Antibody Testing Minimal Dataset

NCT05713136

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: ACT Justice Health Canberra, Australian Capital Territory, Australia

Justice Health and Forensic Mental Health Network Sydney, New South Wales, Australia

Queensland Injectors Health Network Ltd Bowen Hills, Queensland, Australia

West Moreton Hospital and Health Service Brisbane, Queensland, Australia

View Trial Details

Liver Diseases

Liver Diseases trial results

Related conditions